Five Disturbing Things You Didn’t Know About Forensic “Science”
By Jordan Smith,
The Intercept
| 04. 24. 2015
Last week, The Washington Post revealed that in 268 trials dating back to 1972, 26 out of 28 examiners within the FBI Laboratory’s microscopic hair comparison unit “overstated forensic matches in a way that favored prosecutors in more than 95 percent” of the cases. These included cases where 14 people have since been either executed or died in prison.
The hair analysis review — the largest-ever post-conviction review of questionable forensic evidence by the FBI — has been ongoing since 2012. The review is a joint effort by the FBI, Innocence Project and the National Association of Criminal Defense Lawyers. The preliminary results announced last week represent just a small percentage of the nearly 3,000 criminal cases in which the FBI hair examiners may have provided analysis. Of the 329 DNA exonerations to date, 74 involved flawed hair evidence analysis.
While these revelations are certainly disturbing — and the implications alarming — the reality is that they represent the tip of the iceberg when it comes to flawed forensics.
In a landmark 2009 report, the National Academy of Sciences concluded that, aside from DNA, there was...
Related Articles
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...